Prognostic significance of cell cycle parameters in infiltrative ductal breast carcinoma

Journal of Clinical Laboratory Analysis

Volumn 12, Issue 3, 1998, Pages 131-136

  Uzarevic B ^a,c   Petrovecki M ^a   Marusic M ^a   Jakic Razumovic J ^a   Hutinec, Z ^a   Sabioncello, A ^b   Gamulin, S ^a  

^a KBC Zagreb   (Croatia)

^b INSTITUTE OF IMMUNOLOGY   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Breast cancer; DNA flow cytometry; Prognosis

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER GRADING; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; POSTMENOPAUSE; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CELL CYCLE; DNA; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPH NODES; MIDDLE AGED; PLOIDIES; PROGNOSIS; RECEPTORS, STEROID; S PHASE;

EID: 0031958844     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1998)12:3<131::AID-JCLA1>3.0.CO;2-C     Document Type: Article

References (18)

1. Fisher B, Bauer M, Wickerham D, Redmond CK, Fischer ER: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 52:1551-1557, 1983.
2. Williams NN, Daly M. Flow cytometry and prognostic implications in patients with solid tumors. Surg Gynecol Obstet 71:257-264, 1990.
3. Merkel DE, McGurie WL: Ploidy, Proliferative activity and Prognosis: DNA flow cytometry of solid tumors. Cancer 65:1194-1205, 1990.
4. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333-1335, 1983.
5. Vindelov LL: Row microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch B Cell Path 24:227, 1977.
6. Hiddemann W, Schumann J, Andreeff M, et al.: Convention on nomenclature for DNA Cytometry. Cytometry 5:445-446, 1984.
7. Horwitz KB, McGuire WL: Progesterone and progesterone receptors in experimental breast cancer. Cancer Res 37:1733-1738, 1977.
8. Romic-Stojkovic R, Gamulin S: Relationship of cytoplasmic and nuclear receptors and progesterone receptors in human breast cancer. Cancer Res 40:4821-4825, 1980.
9. McGuire WL, Horwitz KB, Zava DT, Carola RE, Chamness: Hormones in breast cancer: Update 1978. Metabolism 27:487-500, 1978.
10. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377, 1957.
11. Dawson Sauders B, Trapp RG: Basic and Clinical Biostatistics. Prentice Hall International, London, 1994.
12. Collett D: Modelling Survival Data in Medical Research. Chapman and Hall, London, 1994.
13. Lewis WE: Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients. Cancer 65:2315-2320, 1990.
14. 0 breast cancer. Am J Clin Pathol 93:471-479, 1990.
15. Hatschek T, Grontoft O, Fagerberg G, et al.: Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: Correlation and relative prognostic influence. Breast Cancer Res Treat 15:149-160, 1990.
16. Spyratos F, Martin PM, Hacene K, et al.: Multiparametric prognostic evaluation of biological factors in primary breast cancer. J Natl Cancer Inst 84:1266-1272, 1992.
17. Beerman H, Kluin M, Hermans J, van de Velde CJH, Cornelisse CJ: Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer 45:34-39, 1990.
18. Noguchi M, Taniya T, Ohta N, Koyasaki N, Miyazaki I, Mizukami Y: Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast. Breast Cancer Res Treat 19:23-31, 1991.